GSK Annual D&A
$2.85 B
+$195.77 M+7.36%
31 December 2023
Summary:
As of January 20, 2025, GSK annual depreciation & amortization is $2.85 billion, with the most recent change of +$195.77 million (+7.36%) on December 31, 2023. During the last 3 years, it has risen by +$223.39 million (+8.49%). GSK annual D&A is now -4.22% below its all-time high of $2.98 billion, reached on December 31, 2019.GSK Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GSK Quarterly D&A
$1.28 B
+$481.89 M+60.05%
30 September 2024
Summary:
As of January 20, 2025, GSK quarterly depreciation & amortization is $1.28 billion, with the most recent change of +$481.89 million (+60.05%) on September 30, 2024. Over the past year, it has increased by +$545.88 million (+73.91%). GSK quarterly D&A is now -57.99% below its all-time high of $3.06 billion, reached on December 31, 2020.GSK Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GSK TTM D&A
$3.52 B
+$535.34 M+17.92%
30 September 2024
Summary:
As of January 20, 2025, GSK TTM depreciation & amortization is $3.52 billion, with the most recent change of +$535.34 million (+17.92%) on September 30, 2024. Over the past year, it has increased by +$667.40 million (+23.38%). GSK TTM D&A is now -36.66% below its all-time high of $5.56 billion, reached on September 30, 2021.GSK TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GSK Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.4% | +73.9% | +23.4% |
| 3 y3 years | +8.5% | +129.0% | +18.1% |
| 5 y5 years | +15.3% | +129.0% | +18.1% |
GSK Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -2.2% | +7.4% | at high | +3514.0% | at high | +69.5% |
| 5 y | 5-year | -4.2% | +8.5% | -58.0% | +188.4% | -36.7% | +574.9% |
| alltime | all time | -4.2% | +918.8% | -58.0% | +188.4% | -36.7% | +574.9% |
GSK Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.28 B(+60.0%) | $3.52 B(+17.9%) |
| June 2024 | - | $802.54 M(+15.3%) | $2.99 B(+7.7%) |
| Mar 2024 | - | $696.35 M(-5.7%) | $2.77 B(-2.9%) |
| Dec 2023 | $2.85 B(+7.4%) | $738.56 M(-1.4%) | $2.85 B(+37.3%) |
| Sept 2023 | - | $749.10 M(+27.2%) | $2.08 B(-11.5%) |
| June 2023 | - | $588.90 M(-24.3%) | $2.35 B(-18.4%) |
| Mar 2023 | - | $777.92 M(-2167.7%) | $2.88 B(+8.2%) |
| Dec 2022 | $2.66 B(-8.9%) | -$37.62 M(-103.7%) | $2.66 B(-14.6%) |
| Sept 2022 | - | $1.02 B(-8.9%) | $3.11 B(-6.5%) |
| June 2022 | - | $1.12 B(+99.3%) | $3.33 B(+11.7%) |
| Mar 2022 | - | $560.82 M(+34.5%) | $2.98 B(+2.2%) |
| Dec 2021 | $2.92 B(+11.0%) | $416.84 M(-66.3%) | $2.92 B(-47.5%) |
| Sept 2021 | - | $1.24 B(+60.8%) | $5.56 B(+9.0%) |
| June 2021 | - | $768.74 M(+54.5%) | $5.10 B(+77.1%) |
| Mar 2021 | - | $497.64 M(-83.7%) | $2.88 B(+9.5%) |
| Dec 2020 | $2.63 B(-11.7%) | $3.06 B(+293.1%) | $2.63 B(-634.6%) |
| Sept 2020 | - | $777.70 M(-153.5%) | -$492.15 M(-33.6%) |
| June 2020 | - | -$1.45 B(-684.3%) | -$741.63 M(-143.9%) |
| Mar 2020 | - | $248.65 M(-478.4%) | $1.69 B(-43.4%) |
| Dec 2019 | $2.98 B(+20.3%) | -$65.71 M(-112.4%) | $2.98 B(-25.5%) |
| Sept 2019 | - | $528.22 M(-45.9%) | $4.00 B(-1.9%) |
| June 2019 | - | $976.53 M(-36.6%) | $4.08 B(+21.6%) |
| Mar 2019 | - | $1.54 B(+61.6%) | $3.35 B(+35.4%) |
| Dec 2018 | $2.48 B(-0.2%) | $953.59 M(+57.4%) | $2.48 B(+96.6%) |
| Sept 2018 | - | $605.67 M(+139.9%) | $1.26 B(-20.9%) |
| June 2018 | - | $252.45 M(-62.0%) | $1.59 B(-41.9%) |
| Mar 2018 | - | $664.66 M(-352.3%) | $2.74 B(+10.5%) |
| Dec 2017 | $2.48 B(+3.2%) | -$263.41 M(-128.1%) | $2.48 B(-31.8%) |
| Sept 2017 | - | $938.76 M(-33.1%) | $3.64 B(+28.4%) |
| June 2017 | - | $1.40 B(+247.4%) | $2.83 B(+41.0%) |
| Mar 2017 | - | $403.77 M(-54.8%) | $2.01 B(-16.4%) |
| Dec 2016 | $2.40 B(-3.5%) | $893.04 M(+571.4%) | $2.40 B(+25.5%) |
| Sept 2016 | - | $133.01 M(-77.0%) | $1.92 B(-11.5%) |
| June 2016 | - | $578.76 M(-27.5%) | $2.17 B(-19.9%) |
| Mar 2016 | - | $798.79 M(+97.1%) | $2.70 B(+8.5%) |
| Dec 2015 | $2.49 B(+1.8%) | $405.30 M(+6.0%) | $2.49 B(+7.7%) |
| Sept 2015 | - | $382.41 M(-65.8%) | $2.31 B(-9.4%) |
| June 2015 | - | $1.12 B(+90.4%) | $2.55 B(+22.5%) |
| Mar 2015 | - | $586.60 M(+158.0%) | $2.08 B(-14.8%) |
| Dec 2014 | $2.45 B(+10.6%) | $227.34 M(-63.5%) | $2.45 B(+54.4%) |
| Sept 2014 | - | $623.48 M(-3.7%) | $1.58 B(-24.9%) |
| June 2014 | - | $647.29 M(-31.7%) | $2.11 B(-7.9%) |
| Mar 2014 | - | $948.08 M(-249.4%) | $2.29 B(+3.6%) |
| Dec 2013 | $2.21 B(-3.4%) | -$634.68 M(-155.2%) | $2.21 B(-43.9%) |
| Sept 2013 | - | $1.15 B(+38.7%) | $3.94 B(+22.7%) |
| June 2013 | - | $828.96 M(-4.5%) | $3.22 B(+15.6%) |
| Mar 2013 | - | $868.33 M(-20.9%) | $2.78 B(+21.5%) |
| Dec 2012 | $2.29 B(+0.3%) | $1.10 B(+160.6%) | $2.29 B(+44.3%) |
| Sept 2012 | - | $421.22 M(+6.9%) | $1.59 B(-23.8%) |
| June 2012 | - | $393.95 M(+4.5%) | $2.08 B(-15.0%) |
| Mar 2012 | - | $376.98 M(-4.5%) | $2.45 B(+7.4%) |
| Dec 2011 | $2.28 B | $394.68 M(-56.9%) | $2.28 B(+5.6%) |
| Sept 2011 | - | $916.43 M(+20.2%) | $2.16 B(-0.7%) |
| June 2011 | - | $762.46 M(+266.1%) | $2.18 B(+5.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | $208.25 M(-24.0%) | $2.07 B(-20.0%) |
| Dec 2010 | $2.59 B(+5.8%) | $274.09 M(-70.6%) | $2.59 B(-4.6%) |
| Sept 2010 | - | $930.95 M(+41.8%) | $2.71 B(+2.9%) |
| June 2010 | - | $656.68 M(-9.6%) | $2.64 B(+14.4%) |
| Mar 2010 | - | $726.65 M(+81.8%) | $2.31 B(-5.7%) |
| Dec 2009 | $2.45 B(+7.5%) | $399.64 M(-53.3%) | $2.45 B(+0.0%) |
| Sept 2009 | - | $855.43 M(+163.2%) | $2.45 B(+6.9%) |
| June 2009 | - | $324.95 M(-62.5%) | $2.29 B(-9.5%) |
| Mar 2009 | - | $866.64 M(+117.0%) | $2.53 B(+11.1%) |
| Dec 2008 | $2.28 B(+11.2%) | $399.29 M(-42.8%) | $2.28 B(+10.2%) |
| Sept 2008 | - | $698.10 M(+23.3%) | $2.07 B(-5.5%) |
| June 2008 | - | $566.12 M(-7.7%) | $2.19 B(+2.9%) |
| Mar 2008 | - | $613.03 M(+226.4%) | $2.12 B(+3.8%) |
| Dec 2007 | $2.05 B(+15.9%) | $187.81 M(-77.1%) | $2.05 B(+4.3%) |
| Sept 2007 | - | $819.15 M(+62.2%) | $1.96 B(+12.9%) |
| June 2007 | - | $504.98 M(-5.7%) | $1.74 B(-8.3%) |
| Mar 2007 | - | $535.58 M(+421.0%) | $1.90 B(+7.3%) |
| Dec 2006 | $1.77 B(+7.4%) | $102.80 M(-82.7%) | $1.77 B(-16.4%) |
| Sept 2006 | - | $594.52 M(-10.3%) | $2.11 B(+8.8%) |
| June 2006 | - | $662.51 M(+63.0%) | $1.94 B(+9.6%) |
| Mar 2006 | - | $406.44 M(-9.7%) | $1.77 B(+7.8%) |
| Dec 2005 | $1.64 B(+4.5%) | $450.23 M(+6.4%) | $1.64 B(+55.1%) |
| Sept 2005 | - | $423.25 M(-14.1%) | $1.06 B(-13.5%) |
| June 2005 | - | $492.77 M(+77.3%) | $1.23 B(-4.0%) |
| Mar 2005 | - | $277.96 M(-308.0%) | $1.28 B(-18.9%) |
| Dec 2004 | $1.57 B(+12.0%) | -$133.62 M(-122.7%) | $1.57 B(-18.7%) |
| Sept 2004 | - | $589.10 M(+8.4%) | $1.94 B(-1.6%) |
| June 2004 | - | $543.35 M(-5.5%) | $1.97 B(+14.4%) |
| Mar 2004 | - | $575.00 M(+152.2%) | $1.72 B(+22.3%) |
| Dec 2003 | $1.40 B(+13.4%) | $228.01 M(-63.2%) | $1.40 B(-1.5%) |
| Sept 2003 | - | $619.59 M(+109.3%) | $1.43 B(+19.0%) |
| June 2003 | - | $296.00 M(+13.3%) | $1.20 B(+4.8%) |
| Mar 2003 | - | $261.25 M(+4.6%) | $1.14 B(-7.6%) |
| Dec 2002 | $1.24 B(+5.8%) | $249.87 M(-36.2%) | $1.24 B(-10.1%) |
| Sept 2002 | - | $391.83 M(+62.2%) | $1.38 B(+5.0%) |
| June 2002 | - | $241.50 M(-32.0%) | $1.31 B(-0.0%) |
| Mar 2002 | - | $355.16 M(-8.6%) | $1.31 B(+12.0%) |
| Dec 2001 | $1.17 B(+5.1%) | $388.41 M(+19.1%) | $1.17 B(-38.3%) |
| Sept 2001 | - | $326.19 M(+35.1%) | $1.90 B(+40.4%) |
| June 2001 | - | $241.50 M(+12.5%) | $1.35 B(+29.4%) |
| Mar 2001 | - | $214.63 M(-80.7%) | $1.04 B(-6.2%) |
| Dec 2000 | $1.11 B(+60.9%) | $1.11 B(-608.7%) | $1.11 B(>+9900.0%) |
| Sept 2000 | - | -$219.01 M(+236.1%) | $100.00(-100.0%) |
| June 2000 | - | -$65.17 M(-122.9%) | $219.01 M(-22.9%) |
| Mar 2000 | - | $284.19 M | $284.19 M |
| Dec 1999 | $692.55 M(+16.7%) | - | - |
| Dec 1998 | $593.35 M(-2.9%) | - | - |
| Dec 1997 | $611.06 M(-4.6%) | - | - |
| Dec 1996 | $640.38 M(-23.9%) | - | - |
| Dec 1995 | $841.29 M(+61.3%) | - | - |
| June 1995 | $521.47 M(+23.6%) | - | - |
| June 1994 | $422.06 M(+15.4%) | - | - |
| June 1993 | $365.73 M(+8.9%) | - | - |
| June 1992 | $335.99 M(+19.9%) | - | - |
| June 1991 | $280.18 M | - | - |
FAQ
- What is GSK annual depreciation & amortization?
- What is the all time high annual D&A for GSK?
- What is GSK annual D&A year-on-year change?
- What is GSK quarterly depreciation & amortization?
- What is the all time high quarterly D&A for GSK?
- What is GSK quarterly D&A year-on-year change?
- What is GSK TTM depreciation & amortization?
- What is the all time high TTM D&A for GSK?
- What is GSK TTM D&A year-on-year change?
What is GSK annual depreciation & amortization?
The current annual D&A of GSK is $2.85 B
What is the all time high annual D&A for GSK?
GSK all-time high annual depreciation & amortization is $2.98 B
What is GSK annual D&A year-on-year change?
Over the past year, GSK annual depreciation & amortization has changed by +$195.77 M (+7.36%)
What is GSK quarterly depreciation & amortization?
The current quarterly D&A of GSK is $1.28 B
What is the all time high quarterly D&A for GSK?
GSK all-time high quarterly depreciation & amortization is $3.06 B
What is GSK quarterly D&A year-on-year change?
Over the past year, GSK quarterly depreciation & amortization has changed by +$545.88 M (+73.91%)
What is GSK TTM depreciation & amortization?
The current TTM D&A of GSK is $3.52 B
What is the all time high TTM D&A for GSK?
GSK all-time high TTM depreciation & amortization is $5.56 B
What is GSK TTM D&A year-on-year change?
Over the past year, GSK TTM depreciation & amortization has changed by +$667.40 M (+23.38%)